Shock waves from a competitor's stumble sent the clinical-stage biotech's shares reeling.
News & Analysis: ChemoCentryx
CCXI earnings call for the period ending March 31, 2019.
CCXI earnings call for the period ending December 31, 2018.
CCXI earnings call for the period ending December 31, 2017
The tiny biopharma stock is cruising on today's news. Does it deserve the pop?
Is this meaningful? Or just another movement?
Ligand Pharmaceuticals, ChemoCentryx, Medivation, and Teva could make health care headlines today. Here's why.
The buddy system works well for three companies this week while three others take a dive following uninspiring clinical-stage news.
The good, bad, and the ugly of health-care stocks this week -- but hold the good.
Development obstacles are mounting for this emerging biotech. Is its therapeutic focus turning into a liability?